Thursday, June 30, 2016

Women Health: Fibroadenomas Prevention - How to avoid

Kyle J. Norton(Scholar, Master of Nutrients), all right reserved.
Health article writer and researcher; Over 10.000 articles and research papers have been written and published on line, including world wide health, ezine articles, article base, healthblogs, selfgrowth, best before it's news, the karate GB daily, etc.,.
Named TOP 50 MEDICAL ESSAYS FOR ARTISTS & AUTHORS TO READ by Named 50 of the best health Tweeters Canada - Huffington Post
Nominated for shorty award over last 4 years
Some articles have been used as references in medical research, such as international journal Pharma and Bio science, ISSN 0975-6299.


Fibroadenomas are benign breast tumors composed of fibrous and glandular tissue which occur mostly in women 30 years old or younger. According to statistic, approximately 500,000-700,000 fibroadenomas are removed each year in US alone. The benign breast tumors are also called breast mice or a breast mouse due to their high mobility in the breast. They are general painless and may become tenderness or swelling just before the menstrual cycle. women with multiple fibroadenomas may indicate a slightly increased risk of breast cancer.

              The Prevention - How to avoid

1. Avoid saturated and trans fat
Saturated and trans fat enhance the production of bad estrogen, which can increase the risk of the disease.

2. Avoid exposure to xanoestrogen
Same as above, exposure to xanoestrogen can increase the production of estrogen.

3. No refined sugar and artificial ingredients
Dieth igh in artificial ingredients and refined sugar can result in high estrogen production.

4. Oral contraceptive pill
In a study of risk factors for breast fibroadenoma in young women. Sitruk-Ware R, Thalabard JC, Benotmane A, Mauvais-Jarvis P., researchers found that Also current use of standard oral contraceptives (SOC) containing 50 micrograms of ethinyl estradiol per pill appeared to be protective and the correlation with FA was negative. These findings underline: (a) the predictive value of premenstrual mastalgia for the subsequent development of breast disease; (b) only current high-dose OC use is protective.

No comments:

Post a Comment